Virex Spray
NDC 83027-0050

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 83027-0050?
  4. Virex Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

Virex (asclepias tuberosa, echinacea purpurea, trifolium pratense, natrum muriaticum, phytolacca decandra, euphrasia officinalis, lac vaccinum (nspc), thuja occidentalis, calcarea arsenicica, camphora, influenzinum, cytomegalovirus nosode, morbillinum, variolinum, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b5 nosode, coxsackie a5 nosode, adenoviren nosode, epstein barr virus nosode, coxsackie b4 nosode) is a UNAPPROVED HOMEOPATHIC-approved product labeled by Nutritional Specialties, Inc.. This medication is typically used as a actively acquired immunity [pe]. It is supplied as a spray for oral administration. This product entry covers the primary NDC 83027-0050 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
83027-0050
Proprietary Name:
Virex
Non-Proprietary Name: [1]
Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinalis, Lac Vaccinum (nspc), Thuja Occidentalis, Calcarea Arsenicica, Camphora, Influenzinum, Cytomegalovirus Nosode, Morbillinum, Variolinum, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B5 Nosode, Coxsackie A5 Nosode, Adenoviren Nosode, Epstein Barr Virus Nosode, Coxsackie B4 Nosode
Substance Name: [2]
Asclepias Tuberosa Root; Calcium Arsenate; Camphor (natural); Cow Milk; Echinacea Purpurea Whole; Euphrasia Stricta; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Coxsackievirus A; Human Coxsackievirus A2; Human Coxsackievirus A7; Human Coxsackievirus B; Human Coxsackievirus B1; Human Coxsackievirus B3; Human Coxsackievirus B5; Human Herpesvirus 4; Human Herpesvirus 5; Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated); Measles Virus; Phytolacca Americana Root; Sodium Chloride; Thuja Occidentalis Leafy Twig; Trifolium Pratense Flower; Variola Virus
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.

Labeler & Regulatory Data

Labeler Name: [5]
Nutritional Specialties, Inc.
Labeler Code:
83027
Product Label ID:
a37728d6-2428-42f7-b331-c07cdc4e9956
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.

Marketing Timeline

Start Marketing Date: [9]
04-13-2023
End Marketing Date: [10]
01-05-2029
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 83027-0050?

The NDC code 83027-0050 is assigned by the FDA to the product Virex. It is commonly known by its generic name, asclepias tuberosa, echinacea purpurea, trifolium pratense, natrum muriaticum, phytolacca decandra, euphrasia officinalis, lac vaccinum (nspc), thuja occidentalis, calcarea arsenicica, camphora, influenzinum, cytomegalovirus nosode, morbillinum, variolinum, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b5 nosode, coxsackie a5 nosode, adenoviren nosode, epstein barr virus nosode, coxsackie b4 nosode. This pharmaceutical product is labeled by Nutritional Specialties, Inc. and is currently categorized as listed product. The medication is a spray administered via oral route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 83027-0050-1. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. Do not take within 15 minutes of consuming food, beverage or brushing teeth. Consult a physician for use in children under 12 years of age.

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • ASCLEPIAS TUBEROSA ROOT (UNII: 1ZL82U5D18)
  • ASCLEPIAS TUBEROSA ROOT (UNII: 1ZL82U5D18) (Active Moiety)
  • ECHINACEA PURPUREA WHOLE (UNII: QI7G114Y98)
  • ECHINACEA PURPUREA (UNII: QI7G114Y98) (Active Moiety)
  • TRIFOLIUM PRATENSE FLOWER (UNII: 4JS0838828)
  • TRIFOLIUM PRATENSE FLOWER (UNII: 4JS0838828) (Active Moiety)
  • SODIUM CHLORIDE (UNII: 451W47IQ8X)
  • CHLORIDE ION (UNII: Q32ZN48698) (Active Moiety)
  • PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG)
  • PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG) (Active Moiety)
  • EUPHRASIA STRICTA (UNII: C9642I91WL)
  • EUPHRASIA STRICTA (UNII: C9642I91WL) (Active Moiety)
  • COW MILK (UNII: 917J3173FT)
  • COW MILK (UNII: 917J3173FT) (Active Moiety)
  • THUJA OCCIDENTALIS LEAFY TWIG (UNII: 1NT28V9397)
  • THUJA OCCIDENTALIS LEAFY TWIG (UNII: 1NT28V9397) (Active Moiety)
  • CALCIUM ARSENATE (UNII: 95OX15I8ZU)
  • ARSENATE ION (UNII: G1DBI405OK) (Active Moiety)
  • CAMPHOR (NATURAL) (UNII: N20HL7Q941)
  • CAMPHOR (NATURAL) (UNII: N20HL7Q941) (Active Moiety)
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 34C49NV47P)
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: NGL844Y7X6) (Active Moiety)
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: P483J7GX6D)
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: GRN94TP8YV) (Active Moiety)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: TBV2PPG6EF)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 28EAH8253X) (Active Moiety)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: H2198F8ZNA)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 3VSF1BF3SR) (Active Moiety)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
  • MEASLES VIRUS (UNII: HT3R7C012Q)
  • MEASLES VIRUS (UNII: HT3R7C012Q) (Active Moiety)
  • VARIOLA VIRUS (UNII: 7J6DBS5FRN)
  • VARIOLA VIRUS (UNII: 7J6DBS5FRN) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A2 (UNII: 82KK5J435E)
  • HUMAN COXSACKIEVIRUS A2 (UNII: 82KK5J435E) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A (UNII: 6F61V9UVRC)
  • HUMAN COXSACKIEVIRUS A (UNII: 6F61V9UVRC) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A7 (UNII: P3026TK92O)
  • HUMAN COXSACKIEVIRUS A7 (UNII: P3026TK92O) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B3 (UNII: 69O1DAO10G)
  • HUMAN COXSACKIEVIRUS B3 (UNII: 69O1DAO10G) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B5 (UNII: 63E6RXM429)
  • HUMAN COXSACKIEVIRUS B5 (UNII: 63E6RXM429) (Active Moiety)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B (UNII: NCM5G1A67U)
  • HUMAN COXSACKIEVIRUS B (UNII: NCM5G1A67U) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes of this product?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the End Marketing Date? This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".